Andere Sprachen Fulgent Genetics, Inc.

Aktien

A2AS4N

US3596641098

FLGT

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 03.05.2024			% 5 Tage	% 1. Jan.
21.5 ^USD	+1.22%		+6.97%	-25.63%

03.05.	Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
03.05.	Fulgent Genetics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M	03.05.
Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	03.05.
Fulgent Reports First Quarter 2024 Financial Results	03.05.
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024	11.04.
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	28.02.
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024	28.02.
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28.02.
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results	28.02.
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M	28.02.
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28	28.02.
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024	13.02.
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels	09.02.
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing	09.02.
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing	09.02.
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference	14.11.
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting	03.11.
Fulgent Genetics, Inc. Announces Two Poster Presentations At SITC 2023 Annual Meeting	03.11.
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.	03.11.
Fulgent Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03.11.
Fulgent Reports Third Quarter 2023 Financial Results	03.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Fulgent Genetics, Inc.

Aktien

A2AS4N

US3596641098

FLGT

Andere Sprachen

Filter